May 2005
Volume 46, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2005
Sources for Superoxide Generation in Axotomized Retinal Ganglion Cells
Author Affiliations & Notes
  • M.J. Hoegger
    Ophthalmology and Visual Science, University of Wisconsin Medical School, Madison, WI
  • L.A. Levin
    Ophthalmology and Visual Science, University of Wisconsin Medical School, Madison, WI
  • Footnotes
    Commercial Relationships  M.J. Hoegger, None; L.A. Levin, None.
  • Footnotes
    Support  NIH EY12492, Retina Research Foundation, Glaucoma Foundation, and Research to Prevent Blindness
Investigative Ophthalmology & Visual Science May 2005, Vol.46, 190. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      M.J. Hoegger, L.A. Levin; Sources for Superoxide Generation in Axotomized Retinal Ganglion Cells . Invest. Ophthalmol. Vis. Sci. 2005;46(13):190.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: Retinal ganglion cells (RGC) undergo apoptosis after axotomy. Our prior studies demonstrated that reactive oxygen species (ROS) such as superoxide play a role in signaling apoptosis after axotomy. Understanding the cellular processes generating the rise in superoxide would help determine the upstream mechanism by which axotomy induces this signal. Methods: Postnatal Longs Evans rats aged two to four days old were retrogradely labeled with the fluorescent dye 4 6–diamidino–2–phenylindole (DAPI) to distinguish RGCs from other retinal cells. Dissociated retinas were plated and superoxide levels measured by treating with dihydroethidium (HEt), a nonfluorescent molecule which becomes fluorescent when oxidized by superoxide and bound to DNA. Fluorescence was measured at 2 and 24 hours after dissociation, in the presence of the following specific inhibitors of superoxide production: rotenone 0.1 µM (inhibits mitochondrial complex I); antimycin A 1 µM (inhibits mitochondrial complex III); indomethacin 100 µM (inhibits cyclooxygenase); allopurinol 100 µM (inhibits xanthine oxidase); diphenyleneiodinium 10 µM (inhibits flavoproteins); or control medium alone. Results: At 2 hours after dissociation the superoxide level was similar for all treatments (p = 0.84 by ANOVA). There was a rise in RGC superoxide at 24 hours, reflecting the effect of axotomy (29.9±1.5 vs. 42.1±2.3 fluorescence units; p = 0.00007). Treatment with antimycin A alone eliminated the rise in fluorescence (20.8±2.5 at 2 hr vs. 21.2±2.5 at 24 hr; p = 0.89). Treatment with other blockers of superoxide generation did not inhibit superoxide production, and in the case of diphenyleneiodinium there was a significant increase in superoxide compared to control (62.4±4.7 vs. 42.1±2.3; p < 0.01 by Tukey HSD post hoc test). Conclusions: Complex III of the mitochondrial electron transport chain may be a source of superoxide generation in RGCs after axotomy, and may represent a target for preventing signaling of apoptosis.

Keywords: ganglion cells • oxidation/oxidative or free radical damage • cell death/apoptosis 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×